αPD-1 and αPD-L1 decreased CD4/CD8 T cell ratio in young and aged co-culture conditions versus isotype controls (Figure 9B), consistent with supporting CD8+ T cell expansion, which is favorable to anti-tumor immunity. The gene discussed is CD4; the disease is neoplasm.